NCT03513523View on ClinicalTrials.gov

Study to Assess the Relationship Between Daily Dosing of NRPT and Changes in Liver Fat in Healthy Volunteers

NACompletedINTERVENTIONAL
Enrollment

111

Participants

Timeline

Start Date

April 18, 2018

Primary Completion Date

May 10, 2020

Study Completion Date

August 17, 2020

Conditions
Fatty Liver
Interventions
DIETARY_SUPPLEMENT

Group 1 NRPT

Two capsules of NRPT and two placebo will be taken once daily in the morning for 26 weeks. Each NRPT capsule will contain 125 mg NR and 25 mg PT.

DIETARY_SUPPLEMENT

Group 2 NRPT

Four capsules of NRPT will be taken once daily in the morning for 26 weeks. Each NRPT capsule will contain 125 mg NR and 25 mg PT.

OTHER

Group 3 Placebo

Four placebo capsules will be taken once daily in the morning for 26 weeks.

Trial Locations (9)

28403

Trial Management Associates, LLC, Wilmington

33012

Indago Research and Health Center, Hialeah

33145

Lone Star Research Center, Miami

33157

IMIC, Inc, Palmetto Bay

33165

Med-Care Research Corp, Miami

33172

Lenus Research & Medical Group, Sweetwater

33461

Altus Research, Inc., Lake Worth

34761

Legacy Clinical Solutions: Sensible Healthcare, LLC, Ocoee

68128

Barrett Clinic, P.C., La Vista

Sponsors

Lead Sponsor

Elysium Health
All Listed Sponsors
collaborator

Nutrasource Pharmaceutical and Nutraceutical Services, Inc.

NETWORK

lead

Elysium Health

INDUSTRY

NCT03513523 - Study to Assess the Relationship Between Daily Dosing of NRPT and Changes in Liver Fat in Healthy Volunteers | Biotech Hunter | Biotech Hunter